Hormone Refractory
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Sutent Maintenance After Response to Taxotere (NCT00550810) | Alberta Health services | 2007-10-01 |
| E3-Hormone Refractory Prostrate Cancer Taxotere Combination (NCT00498797) | Sanofi | 2005-12-01 |
Track Hormone Refractory automatically
Every clearance here is in the API, with alerts when new ones post.